You searched for "intracameral"
Intravitreal bevacizumab vs. ranibizumab in the treatment of macular oedema due to BRVO
This is a randomised, prospective, non-inferiority trial of 75 patients with macular oedema due to a branch retinal vein occlusion (BRVO) who received intravitreal injections of ranibizumab or bevacizumab after 1:1 block randomisation. This study is to measure the difference...
Intravitreal ranibizumab for the treatment of myopic CNV
The authors conducted a prospective study. Sixty-four patients (65 eyes) attended the 12-month follow-up examination. The mean patient age was 47.8 years. Fifty-five patients (86.0%) were females. All patients had pathologic myopia (a spherical equivalent of more than − 6.0...
Ranibizumab safety in pregnancy
Vascular endothelial growth factor (VEGF) plays a pivotal role during pregnancy, and systemic anti-VEGF administration during this period should thus be avoided. VEGF is expressed in multiple embryonic and foetal tissues during development, with the highest levels found in the...
2018 update on intravitreal injections
In this review article the authors have highlighted the standardised and structured approach to intravitreal injections (IVI) by examining the recent evidence-based literature. IVI is the most commonly performed procedure worldwide with low potential risk of endophthalmitis. IOP spikes are...Intravitreal injections delivered by ophthalmic clinical nurse specialists
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...Management of retinal diseases: highlights from the AAO 2019 Retina Subspecialty Day Meeting
The author highlights current debate, opinion and late breaking developments in the management of retinal diseases. The American Academy of Ophthalmology’s 2019 Retina Subspecialty Day Meeting was held on 11-12 October, 2019 in San Francisco, USA. Established and emerging innovative...The approach to trabeculectomy postoperative complications
Performing a trabeculectomy is like giving birth to a baby. It may be traumatic and there is scope for devastating error but once the operation is completed only then does the real work begin. The bleb must be nurtured into...Dr Sohaib Rufai awarded European Award in Medicine for Ophthalmology
Dr Sohaib Rufai has been awarded the 2022 European Award in Medicine for Ophthalmology. He led the world’s first study using handheld OCT to predict future vision in infantile nystagmus.CHEC announces national online CPD event covering critical eye condition that has seen 400% increase in secondary care referrals
CHEC announces national online CPD event covering critical eye condition that has seen 400% increase in secondary care referrals. The seminar is to be hosted by CHEC Clinical Director Mahmoud Rabie and follows the UK rollout of CHEC’s ground-breaking YAG Quantel Capsulo Laser System which significantly improves accuracy in eye treatments.OKKO Health announce collaboration with the University of Plymouth to measure vision in extreme environments including space
OKKO Health, a leader in innovative eye health technology, is excited to announce its collaboration with the University of Plymouth. This groundbreaking project will test eye health and track early disease detection in extreme environments, beginning with the depths of a cave and soon to monitor astronauts’ vision in the vastness of space.The impact of obstructive sleep apnoea monitoring functionality on smartwatches: a new frontier for ophthalmologists
Dawn of a new era in wearable technology? Smartwatches have really stepped up their game and have evolved from telling time to keeping an eye on our health. In February 2024, the United States Food and Drug Administration (FDA) gave...
